Sanofi-backed Electra files for IPO to fund Phase 2/3 immunology drug

Biotech's IPO summer isn't over yet. Electra Therapeutics plans to begin public trading on the Nasdaq after the Labor Day holiday, according to a Friday IPO filing with securities regulators. While ...